B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes

Immunity

Volumn 20, Issue 3, 2004, Pages 327-336

  Dong, Haidong ^a   Zhu, Gefeng ^a   Tamada, Koji ^a   Flies, Dallas B ^a   Van Deursen, Jan M A ^a   Chen, Lieping ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN; PROTEIN B7 H1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; LIVER CELL; LIVER CELL DAMAGE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD80; APOPTOSIS; AUTOIMMUNE DISEASES; BLOOD PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; HEPATITIS, ANIMAL; KINETICS; LIVER; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PEPTIDES;

EID: 1642306942     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(04)00050-0     Document Type: Article

References (46)

1. Adachi M., Suematsu S., Suda T., Watanabe D., Fukuyama H., Ogasawara J., Tanaka T., Yoshida N., Nagata S. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA. 93:1996;2131-2136.
2. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J.et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:2003;63-69.
3. Bonfoco E., Stuart P.M., Brunner T., Lin T., Griffith T.S., Gao Y., Nakajima H., Henkart P.A., Ferguson T.A., Green D.R. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity. 9:1998;711-720.
4. Brown J.A., Dorfman D.M., Ma F.R., Sullivan E.L., Munoz O., Wood C.R., Greenfield E.A., Freeman G.J. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170:2003;1257-1266.
5. Carreno B.M., Collins M. The B7 family of ligands and its receptors. new pathways for costimulation and inhibition of immune responses Annu. Rev. Immunol. 20:2002;29-53.
6. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J., Carreno B.M. PD-1:pd-l inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32:2002;634-643.
7. Chen D., McKallip R.J., Zeytun A., Do Y., Lombard C., Robertson J.L., Mak T.W., Nagarkatti P.S., Nagarkatti M. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection. evidence for involvement of CD44 in activation-induced cell death J. Immunol. 166:2001;5889-5897.
8. Crispe I.N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3:2003;51-62.
9. Crispe I.N., Dao T., Klugewitz K., Mehal W.Z., Metz D.P. The liver as a site of T-cell apoptosis. graveyard or killing field? Immunol. Rev. 174:2000;47-62.
10. Dao T., Exley M., Mehal W.Z., Tahir S.M., Snapper S., Taniguchi M., Balk S.P., Crispe I.N. Involvement of CD1 in peripheral deletion of T lymphocytes is independent of NK T cells. J. Immunol. 166:2001;3090-3097.
11. Davidson W.F., Dumont F.J., Bedigian H.G., Fowlkes B.J., Morse H.C. III. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J. Immunol. 136:1986;4075-4084.
12. Dini L. Recognizing death. liver phagocytosis of apoptotic cells Eur. J. Histochem. 44:2000;217-227.
13. Dong H., Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81:2003;281-287.
14. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1999;1365-1369.
15. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K.et al. Tumor-associated B7-H1 promotes T-cell apoptosis. a potential mechanism of immune evasion Nat. Med. 8:2002;793-800.
16. Ehl S., Hoffmann-Rohrer U., Nagata S., Hengartner H., Zinkernagel R. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J. Immunol. 156:1996;2357-2360.
17. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C.et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:2000;1027-1034.
18. Green D.R., Droin N., Pinkoski M. Activation-induced cell death in T cells. Immunol. Rev. 193:2003;70-81.
19. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J., Marrack P. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 16:2002;759-767.
20. Huang L., Soldevila G., Leeker M., Flavell R., Crispe I.N. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity. 1:1994;741-749.
21. Iwai Y., Terawaki S., Ikegawa M., Okazaki T., Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198:2003;39-50.
22. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., Taniguchi M. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:2000;105-114.
23. Kawabe Y., Ochi A. Programmed cell death and extrathymic reduction of Vβ8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature. 349:1991;245-248.
24. Krueger A., Fas S.C., Baumann S., Krammer P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193:2003;58-69.
25. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R.et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:2001;261-268.
26. Liu Z.X., Govindarajan S., Okamoto S., Dennert G. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J. Immunol. 166:2001;3035-3041.
27. Liu X., Gao J.X., Wen J., Yin L., Li O., Zuo T., Gajewski T.F., Fu Y.X., Zheng P., Liu Y. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J. Exp. Med. 197:2003;1721-1730.
28. Luettig B., Pape L., Bode U., Bell E.B., Sparshott S.M., Wagner S., Westermann J. Naive and memory T lymphocytes migrate in comparable numbers through normal rat liver. activated T cells accumulate in the periportal field J. Immunol. 163:1999;4300-4307.
29. Mehal W.Z., Crispe I.N. TCR ligation on CD8+ T cells creates double-negative cells in vivo. J. Immunol. 161:1998;1686-1693.
30. Mehal W.Z., Azzaroli F., Crispe I.N. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J. Immunol. 167:2001;667-673.
31. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Satoh S., Niwa M., Senoh H., Fujiwara H. T cell activation-associated hepatic injury. mediation by tumor necrosis factors and protection by interleukin 6 J. Exp. Med. 179:1994;1529-1537.
32. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:1999;141-151.
33. Salama A.D., Chitnis T., Imitola J., Akiba H., Tushima F., Azuma M., Yagita H., Sayegh M.H., Khoury S.J. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:2003;71-78.
34. Salomon B., Bluestone J.A. Complexities of CD28/B7:CTLA-4 costimulatory pathway in autoimmunity and transplantation. Annu. Rev. Immunol. 19:2001;225-253.
35. Selenko-Gebauer N., Majdic O., Szekeres A., Hofler G., Guthann E., Korthauer U., Zlabinger G., Steinberger P., Pickl W.F., Stockinger H.et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170:2003;3637-3644.
36. Shin T., Kennedy G., Gorski K., Tsuchiya H., Koseki H., Azuma M., Yagita H., Chen L., Powell J., Pardoll D., Housseau F. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J. Exp. Med. 198:2003;31-38.
37. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 18:2003;849-861.
38. Suzuki I., Fink P.J. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proc. Natl. Acad. Sci. USA. 97:2000;1707-1712.
39. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M.et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity. 14:2001;523-534.
40. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA. 97:2000;5498-5503.
41. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:2001;1809-1816.
42. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:1992;196-203.
43. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:2001;839-846.
44. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197:2003;1083-1091.
45. Wick M.J., Leithauser F., Reimann J. The hepatic immune system. Crit. Rev. Immunol. 22:2002;47-103.
46. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K.et al. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169:2002;5538-5545.